Overview
Adam Zimilover is a primary care provider, practicing in Infectious Disease in Bronx, New York. Dr. Zimilover is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, and Histiocytosis.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Methicillin-Resistant Staphylococcus Aureus (MRSA).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE SNP
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- PPO
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
111 East 210th Street, Bronx, NY 10461
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Trustees Of Columbia University In The City Of New York
Anne-catrin Uhlemann is an Infectious Disease provider in New York, New York. Dr. Uhlemann is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, Sepsis, and Severe Acute Respiratory Syndrome (SARS).
New York University
Bo Shopsin is an Infectious Disease provider in New York, New York. Dr. Shopsin is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Hospital-Acquired Pneumonia, Sepsis, and Mediastinitis.
Paul Planet is a Pediatric Infectious Disease specialist and an Infectious Disease provider in New York, New York. Dr. Planet is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Neonatal Sepsis, Sepsis, and Malaria.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hemophagocytic LymphohistiocytosisDr. Zimilover isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- HistiocytosisDr. Zimilover isExperienced. Learn about Histiocytosis.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Non-Langerhans-Cell HistiocytosisDr. Zimilover isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaDr. Zimilover isExperienced. Learn about Reticulohistiocytoma.